A distinct IgM immunoblot signature differentiates neurosyphilis from latent syphilis

Accurately differentiating neurosyphilis (NS) from latent syphilis (LS) is essential, as it directly guides therapeutic decisions and prevents devastating neurological complications. However, this differentiation remains a significant clinical challenge because it currently relies on cerebrospinal fluid analysis-an invasive and resource-intensive procedure that is not suitable for all patients. To address this, we evaluated whether a detailed Treponema pallidum-specific immunoglobulin M (IgM) immunoblot profile could offer a robust non-invasive diagnostic tool. We conducted a comprehensive analysis of serum samples from 319 patients (74 NS and 245 LS), assessing the IgM positive rate, antigen-specific reactivity (TP15, TP17, TP45, and TP47), and antibody reaction intensity (gray value). Our analysis revealed that NS patients exhibited a significantly stronger and broader IgM response, evidenced by a higher overall positive rate (45.9% vs 26.1%, P = 0.001) and elevated reactivity to TP17, TP45, and TP47 antigens. The antibody reaction intensity for these antigens was also significantly stronger in the NS group. Critically, multivariable analysis identified a higher serum the Toluidine Red Unheated Serum Test titer (odds Ratio [OR] = 1.025 per unit, 95% confidence interval [CI]: 1.009-1.041, P = 0.003) and a greater number of positive antigens (OR = 1.663, 95% CI: 1.100-2.512, P = 0.016) as independent risk factors for NS, while male sex was an independent protective factor (OR = 0.325, 95% CI: 0.179-0.591, P < 0.001). These findings demonstrate that the IgM immunoblot provides a distinct serological signature, offering a valuable non-invasive aid for discriminating NS from LS.

This study addresses a fundamental challenge in syphilis management: determining which patients with latent syphilis are at high risk for neurosyphilis without relying on invasive lumbar puncture. By analyzing a simple blood test that profiles the immunoglobulin M antibody response in detail, we discovered that patients with neurosyphilis have a distinctly stronger and broader immune reaction. We further identified key risk factors, including higher antibody levels and reactivity to multiple targets. These findings are significant because they provide doctors with a practical, non-invasive tool to stratify patient risk more accurately. This can help optimize clinical decision-making, ensuring that lumbar punctures are performed on patients who need them most while avoiding unnecessary procedures for others, ultimately leading to better and more personalized patient care.